Abstract:A novel kind of monodisperse mesoporous manganese silicate coated silica nanoparticle (MMSSN) as a highly efficient T1-weighted MRI contrast agent (CA) and drug carrier for cancer diagnosis and chemotherapy has been constructed by a modified "SiO2 sacrifice and in situ silicate growth" approach under a relatively low hydrothermal temperature and alkali-free condition. The mesoporous manganese silicate shell provides a large specific surface area and abundant exposed Mn paramagnetic centers to water molecules, which endows the MMSSNs with extraordinarily high longitudinal relaxivity. Meanwhile, the MMSSNs presented an efficient pH/redox-responsive T1-MRI feature based on the significant enhancement of relaxation rate (r1) stimulated by mild acidic environment or reducing agent (GSH) both in vitro and in vivo. Furthermore, the mesoporous structure and negatively charged pore surface of the manganese silicate shell enable the MMSSNs to attain anti-cancer drug (DOX) storage and a pH-responsive release, which is suitable for on-demand drug release for the chemotherapy of tumors. Therefore, the mesoporous manganese silicate-based nanomaterial is a promising candidate as T1-MRI CAs and anticancer-drug delivery carriers for the theranostics of tumor in an intelligent and on-demand manner. STATEMENT OF SIGNIFICANCE:MRI is one of the most frequently used imaging techniques in daily clinics for cancer diagnosis. Using contrast agents (CAs) in MRI can afford much clearer and enlarged images of detectable organs. Gadolinium (Gd(3+))-based T1-positive CAs are widely used but associated with the risk of nephrogenic systemic fibrosis. To achieve much safer CAs, various Mn(2+)-based T1-positive CAs have been reported, such as MnO or core-shell MnOx-based nanoparticles. However, the efficiency of these CAs is still lower. Herein, we report a novel kind of mesoporous manganese silicate coated silica nanoparticle as CA and anti-cancer drug carrier. Results obtained from this study, especially the pH/redox-responsive T1-MRI feature are helpful for us to further design efficient MnSiO3-based materials for clinical MRI applications.

Tannic acid-mediated synthesis of flower-like mesoporous MnO2 nanostructures as T1–T2 dual-modal MRI contrast agents and dual-enzyme mimetic agents

Structure-property Relationships in Manganese Oxide - Mesoporous Silica Nanoparticles Used for T1-weighted MRI and Simultaneous Anti-Cancer Drug Delivery

Controlled Synthesis Of Mnfe2o4 Nanoparticles And Gd Complex-Based Nanocomposites As Tunable And Enhanced T-1/T-2-Weighted Mri Contrast Agents

Cationic Polyelectrolyte Mediated Synthesis of MnO2-Based Core-Shell Structures as Activatable MRI Theranostic Platform for Tumor Cell Ablation

Manganese Oxide/metal-Organic Frameworks-Based Nanocomposites for Tumr Micro-environment Sensitive 1H/19F Dual-mode Magnetic Resonance Imaging in Vivo

Manganese-Loaded Dual-Mesoporous Silica Spheres for Efficient T1- and T2-Weighted Dual Mode Magnetic Resonance Imaging

Synthesis and characterization of PEG-coated Zn$_{0.3}$Mn$_x$Fe$_{2.7-x}$O$_4$ nanoparticles as the dual T1/T2-weighted MRI contrast agent

A Manganese Porphyrin Platform for the Design and Synthesis of Molecular and Targeted MRI Contrast Agents

Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI

Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers.

Manganese Oxide Nanoparticles for MRI-Based Multimodal Imaging and Theranostics

Transition Metal (Molybdenum)-Doped Drug-like Conformational Nanoarchitectonics with Altered Valence States (Mn2+/Mn4+ and Mo5+/Mo6+) for Augmented Cancer Theranostics

Versatile in situ synthesis of MnO2 nanolayers on upconversion nanoparticles and their application in activatable fluorescence and MRI imaging.

Tuneable Manganese Oxide Nanoparticle Based Theranostic Agents for Potential Diagnosis and Drug Delivery

Biocompatible and High-Performance Amino Acids-Capped MnWO4 Nanocasting As a Novel Non-Lanthanide Contrast Agent for X-ray Computed Tomography and T1-weighted Magnetic Resonance Imaging

Zwitterion-Coated Ultrasmall MnO Nanoparticles Enable Highly Sensitive T 1 -Weighted Contrast-Enhanced Brain Imaging

Plant mediated biosynthesis of Mn3O4 nanostructures and their biomedical applications

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo

Synthesis, Characterization, and In Vitro Study of Dextrin-Coated Bismuth-Doped Manganese Ferrite Nanoparticles (Bio.3Mno.55Fe2O4) as an MRI Contrast Agent

Mn(II) based T1 and T2 potential MRI contrast agent appended with tryptamine: Recognition moiety for Aβ-plaques

Nanoarchitectured manganese dioxide (MnO2)-based assemblies for biomedicine